Allan, John N., Javier Pinilla-Ibarz, Douglas E. Gladstone, Krish Patel, Jeff P. Sharman, William G. Wierda, Michael Y. Choi, Susan M. O’Brien, Mazyar Shadman, Matthew S. Davids, John M. Pagel, Habte A. Yimer, Renee Ward, Gary Acton, Pietro Taverna, Daniel L. Combs, Judith A. Fox, Richard R. Furman, and Jennifer R. Brown. 2022. “Phase Ib Dose-Escalation Study of the Selective, Non-Covalent, Reversible Bruton’s Tyrosine Kinase Inhibitor Vecabrutinib in B-Cell Malignancies”. Haematologica 107 (4). Pavia, Italy, 984-87. https://doi.org/10.3324/haematol.2021.280061.